Novartis Korea, Dongwha expand cooperation

Novartis Korea and Dongwha Pharmaceutical has recently agreed to further cooperation in over-the-counter (OTC) drugs field.

Both company signed an agreement to promote co-marketing of Novartis’s Lamisil, which had been marketed by Pacific Pharm.

Lamisil is commonly prescribed for the treatment of fingernail or toenail fungus, as well as ringworm of the scalp. The medication acts on certai...